Synovus Financial Corp Sanofi Transaction History

Synovus Financial Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$38.86 - $48.55 $217,616 - $271,880	5,600 New	5,600 $271,000
Q3 2020 Nov 09, 2020	SELL	$49.47 - $53.77 $144,798 - $157,384	-2,927 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$42.91 - $52.5 $119,075 - $145,687	-2,775 Reduced 48.67%	2,927 $149,000
Q1 2020 Apr 24, 2020	BUY	$38.02 - $51.66 $126,644 - $172,079	3,331 Added 140.49%	5,702 $249,000
Q4 2019 Feb 06, 2020	SELL	$44.25 - $50.86 $4,425 - $5,086	-100 Reduced 4.05%	2,371 $119,000
Q3 2019 Nov 01, 2019	SELL	$40.34 - $46.64 $1,613 - $1,865	-40 Reduced 1.59%	2,471 $114,000
Q2 2019 Aug 08, 2019	BUY	$40.43 - $44.3 $4,366 - $4,784	108 Added 4.49%	2,511 $109,000
Q4 2018 Feb 07, 2019	BUY	$41.48 - $45.59 $1,327 - $1,458	32 Added 1.35%	2,403 $104,000
Q3 2018 Nov 01, 2018	SELL	$40.0 - $44.84 $56,080 - $62,865	-1,402 Reduced 37.16%	2,371 $106,000
Q1 2018 May 07, 2018	SELL	$38.98 - $45.76 $54,182 - $63,606	-1,390 Reduced 26.92%	3,773 $150,000
Q4 2017 Feb 09, 2018	BUY	$42.86 - $50.61 $221,286 - $261,299	5,163	5,163 $224,000

823

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $125B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.